Increased expression of Tim-3 has been reported on leukemic stem cells (LSCs), and not on healthy HSCs in MDS [48,49].Therefore, TIM3 could represent a promising marker for detecting malignant clone cells in MDS, as well as being a candidate for targeted therapy [49]. The gene discussed is HAVCR2; the disease is myelodysplastic syndrome.